Central Nervous System Cancers Panel - Disclosures as of 9/2/2010
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Philip J. Bierman, MD |
Bradmer Pharmaceuticals |
None |
None |
None |
9/18/2009 |
Henry Brem, MD |
None |
None |
None |
None |
11/5/2009 |
Steven Brem, MD |
None |
Eisai, Inc. |
None |
None |
1/4/2010 |
Nicholas Butowski, MD |
None |
None |
None |
None |
9/11/2009 |
Marc C. Chamberlain, MD |
NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas |
Enzon Pharmaceuticals; |
None |
None |
4/13/2010 |
E. Antonio Chiocca, MD, PhD |
None |
None |
None |
None |
11/23/2009 |
Lisa M. DeAngelis, MD |
None |
Genentech, Inc. |
None |
None |
12/4/2009 |
Robert A. Fenstermaker, MD |
None |
None |
None |
None |
11/13/2009 |
Allan Friedman, MD |
None |
None |
None |
None |
1/4/2010 |
Lauren Gallagher, RPh, PhD |
None |
None |
None |
None |
8/23/2010 |
Mark R Gilbert, MD |
RTOG Trial |
Genentech, Inc.; |
None |
None |
12/2/2009 |
Kristina M. Gregory, RN, MSN, OCN |
None |
None |
None |
None |
8/30/2010 |
Deneen Hesser, MSHSA, RN, OCN |
None |
None |
None |
Genentech, Inc.; |
11/10/2009 |
Maria Ho, PhD |
None |
None |
None |
None |
7/15/2010 |
Larry Junck, MD |
Genentech, Inc. |
Genentech, Inc. |
None |
None |
11/16/2009 |
Gerald P. Linette, MD, PhD |
None |
None |
None |
None |
9/28/2009 |
Jay S. Loeffler, MD |
None |
Genentech, Inc.; |
None |
None |
7/21/2009 |
Moshe H Maor, MD |
None |
None |
None |
None |
8/4/2009 |
Joan S. McClure, MS |
None |
None |
None |
None |
7/18/2010 |
Nicole McMillian, MS |
None |
None |
None |
None |
7/15/2010 |
Madison Michael, MD |
Pending |
||||
Paul L. Moots, MD |
ECOG; |
None |
None |
None |
11/16/2009 |
Tara Morrison, MD, FRCPC |
None |
Genentech, Inc. |
None |
None |
9/25/2009 |
Maciej M. Mrugala, MD, PhD, MPH |
None |
Enzon Pharmaceuticals; |
None |
None |
11/24/2009 |
Louis Burt Nabors, MD |
AstraZeneca Pharmaceuticals LP; |
Merck KGaA |
None |
None |
4/27/2010 |
Herbert B. Newton, MD |
None |
Eisai Inc.; |
None |
None |
9/28/2009 |
Jana Portnow, MD |
None |
None |
None |
None |
9/24/2009 |
Jeffrey J. Raizer, MD |
Eli Lilly and Company; |
Enzon Pharmaceuticals; |
None |
None |
11/30/2009 |
Lawrence Recht, MD |
Genentech, Inc.; |
Genentech, Inc. |
None |
None |
12/9/2009 |
Dennis C. Shrieve, MD, PhD |
None |
None |
None |
None |
9/28/2009 |
Allen K. Sills, MD |
None |
None |
None |
None |
11/24/2009 |
Frank D. Vrionis, MD, MPH, PhD |
Synthes Stryker |
Medtronic, Inc.; |
None |
None |
4/21/2010 |
Patrick Yung Wen, MD |
None |
Genentech, Inc. |
None |
None |
7/7/2010 |
Privacy Policy| Legal Notices| Site Map| Contact Us| Help
Copyright © 2010 National Comprehensive Cancer Network, All Rights Reserved